$OPGN
OPGEN INC

2017 Q2 Form 10-Q Financial Statement

#000156459017017267 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $703.2K $1.183M
YoY Change -40.55% 215.3%
Cost Of Revenue $470.0K $161.2K
YoY Change 191.52% 194.23%
Gross Profit $230.0K $1.022M
YoY Change -77.49% 218.9%
Gross Profit Margin 32.71% 86.37%
Selling, General & Admin $2.660M $3.366M
YoY Change -20.97% 44.7%
% of Gross Profit 1156.52% 329.45%
Research & Development $1.760M $2.334M
YoY Change -24.58% 133.43%
% of Gross Profit 765.22% 228.42%
Depreciation & Amortization $160.0K $160.0K
YoY Change 0.0% 60.0%
% of Gross Profit 69.57% 15.66%
Operating Expenses $4.420M $6.197M
YoY Change -28.68% 80.75%
Operating Profit -$4.190M -$5.015M
YoY Change -16.44% 64.22%
Interest Expense -$40.00K $26.65K
YoY Change -250.1% -98.22%
% of Operating Profit
Other Income/Expense, Net -$38.29K
YoY Change -98.34%
Pretax Income -$4.210M -$5.050M
YoY Change -16.63% -5.78%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.210M -$5.053M
YoY Change -16.68% -5.7%
Net Earnings / Revenue -598.68% -427.19%
Basic Earnings Per Share
Diluted Earnings Per Share -$38.27M -$168.3M
COMMON SHARES
Basic Shares Outstanding 27.39M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.0K $8.030M
YoY Change -97.38% -21.43%
Cash & Equivalents $211.7K $8.025M
Short-Term Investments
Other Short-Term Assets $420.0K $560.0K
YoY Change -25.0% 14.29%
Inventory $580.0K $844.3K
Prepaid Expenses
Receivables $410.0K $871.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.630M $10.30M
YoY Change -84.18% -8.56%
LONG-TERM ASSETS
Property, Plant & Equipment $780.0K $922.2K
YoY Change -15.42% 90.86%
Goodwill $600.8K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $313.8K $270.4K
YoY Change 16.06% 483.04%
Total Long-Term Assets $3.361M $3.548M
YoY Change -5.28% 570.09%
TOTAL ASSETS
Total Short-Term Assets $1.630M $10.30M
Total Long-Term Assets $3.361M $3.548M
Total Assets $4.991M $13.85M
YoY Change -63.97% 17.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.907M $1.901M
YoY Change 52.94% 70.35%
Accrued Expenses $972.6K $797.1K
YoY Change 22.03% 36.52%
Deferred Revenue
YoY Change
Short-Term Debt $629.7K $179.6K
YoY Change 250.68%
Long-Term Debt Due $170.0K $230.0K
YoY Change -26.09% 91.67%
Total Short-Term Liabilities $5.514M $4.159M
YoY Change 32.59% 50.79%
LONG-TERM LIABILITIES
Long-Term Debt $1.180M $1.220M
YoY Change -3.28% 480.95%
Other Long-Term Liabilities $440.0K $530.0K
YoY Change -16.98%
Total Long-Term Liabilities $1.620M $1.750M
YoY Change -7.43% 733.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.514M $4.159M
Total Long-Term Liabilities $1.620M $1.750M
Total Liabilities $7.130M $5.910M
YoY Change 20.64% 99.07%
SHAREHOLDERS EQUITY
Retained Earnings -$123.7M
YoY Change 18.1%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.140M $7.945M
YoY Change
Total Liabilities & Shareholders Equity $4.990M $13.85M
YoY Change -63.97% 17.41%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$4.210M -$5.053M
YoY Change -16.68% -5.7%
Depreciation, Depletion And Amortization $160.0K $160.0K
YoY Change 0.0% 60.0%
Cash From Operating Activities -$3.200M -$5.490M
YoY Change -41.71% 91.96%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K -$50.00K
YoY Change 180.0% 150.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$140.0K -$50.00K
YoY Change 180.0% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.900M 9.590M
YoY Change -80.19% -23.03%
NET CHANGE
Cash From Operating Activities -3.200M -5.490M
Cash From Investing Activities -140.0K -50.00K
Cash From Financing Activities 1.900M 9.590M
Net Change In Cash -1.440M 4.050M
YoY Change -135.56% -57.72%
FREE CASH FLOW
Cash From Operating Activities -$3.200M -$5.490M
Capital Expenditures -$140.0K -$50.00K
Free Cash Flow -$3.060M -$5.440M
YoY Change -43.75% 91.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
179150
CY2016Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
313828
CY2017Q2 us-gaap Assets
Assets
4991040
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2907190
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
798069
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
972632
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
37760
CY2017Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
629702
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
168831
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5514184
CY2017Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
347648
CY2016Q4 opgn Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
0
CY2017Q2 opgn Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
89291
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
1975365
CY2016Q2 opgn Laboratory Services Revenue
LaboratoryServicesRevenue
29674
opgn Laboratory Services Revenue
LaboratoryServicesRevenue
31955
opgn Laboratory Services Revenue
LaboratoryServicesRevenue
159094
CY2016Q2 opgn Collaborations Revenue
CollaborationsRevenue
125000
opgn Collaborations Revenue
CollaborationsRevenue
27397
opgn Collaborations Revenue
CollaborationsRevenue
125000
CY2016Q2 us-gaap Revenues
Revenues
1182820
us-gaap Revenues
Revenues
1474981
us-gaap Revenues
Revenues
2259459
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
337020
us-gaap Cost Of Goods Sold
CostOfGoodsSold
817741
us-gaap Cost Of Goods Sold
CostOfGoodsSold
682987
CY2016Q2 us-gaap Cost Of Services
CostOfServices
161222
us-gaap Cost Of Services
CostOfServices
178996
us-gaap Cost Of Services
CostOfServices
476931
CY2017Q2 opgn Interest And Other Income Expense
InterestAndOtherIncomeExpense
22
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26744
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26744
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2017Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4208047
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28210657
CY2017Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3834
us-gaap Repayments Of Debt
RepaymentsOfDebt
53047
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
108095
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4211881
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
324412
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Accretion Expense
AccretionExpense
19498
us-gaap Accretion Expense
AccretionExpense
2083
us-gaap Share Based Compensation
ShareBasedCompensation
454712
us-gaap Share Based Compensation
ShareBasedCompensation
527896
opgn Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
7560
opgn Proceeds From Stock Options And Warrant Exercises
ProceedsFromStockOptionsAndWarrantExercises
23512
us-gaap Repayments Of Debt
RepaymentsOfDebt
25328
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
121170
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3936929
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9542658
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7023
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3103
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3905641
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
210803
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7814220
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8025023
us-gaap Interest Paid
InterestPaid
36131
us-gaap Interest Paid
InterestPaid
28777
opgn Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
179150
opgn Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
0
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying condensed consolidated financial statements, estimates are used for, but not limited to, share-based compensation, allowances for doubtful accounts and inventory obsolescence, valuation of derivative financial instruments and other liabilities measured at fair value on a recurring basis, beneficial conversion features of convertible debt, deferred tax assets and liabilities and related valuation allowance, depreciation and amortization and estimated useful lives of long-lived assets. Actual results could differ from those estimates.</p></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
opgn Number Of Individual Customers Accounting For More Than Ten Percent Of Revenue
NumberOfIndividualCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2017Q2 opgn Number Of Individual Customers Accounting For More Than Ten Percent Of Revenue
NumberOfIndividualCustomersAccountingForMoreThanTenPercentOfRevenue
0
CY2017Q2 opgn Number Of Individual Customers Accounting For More Than Ten Percent Of Accounts Receivable
NumberOfIndividualCustomersAccountingForMoreThanTenPercentOfAccountsReceivable
0
CY2017Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
329904
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
479479
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
48185
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
27422
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
200814
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
185467
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
148160
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
704516
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2013000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
525910
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2013000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
392002
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
133908
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
133908
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
268000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
268000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
268000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
268000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
268000
CY2017Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14300000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16300000
opgn Fair Value Assets Between Levels Transfers Amount
FairValueAssetsBetweenLevelsTransfersAmount
0
CY2016Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9500000
opgn Convertible Preferred Stock Beneficial Conversion Feature Recognized As Deemed Dividend
ConvertiblePreferredStockBeneficialConversionFeatureRecognizedAsDeemedDividend
332550
CY2017Q2 opgn Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
209307
CY2016Q2 opgn Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
266399
opgn Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
454712
opgn Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
527896
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
146000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
869600
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.73
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.98
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
303047
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
307910
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.47
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10904942
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10506524
us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
The Company leases a facility in Woburn, Massachusetts under an operating lease that expires January 30, 2022. The Company also leases a facility in Gaithersburg, Maryland under an operating lease that expires January 31, 2021, with one additional five-year renewal at the Company’s election. Additionally, the Company leases office space in Denmark; this lease is currently on a month-to-month basis.
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
238703
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
248345
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
471539
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
502389
us-gaap Description Of Lessee Leasing Arrangements Capital Leases
DescriptionOfLesseeLeasingArrangementsCapitalLeases
The Company leases computer equipment, office furniture, and equipment under various capital leases. The leases expire at various dates through 2021. The leases require monthly principal and interest payments.
opgn Capital Leases Expiration Date Description
CapitalLeasesExpirationDateDescription
The leases expire at various dates through 2021.
CY2017Q2 opgn One Time Restructuring Benefits
OneTimeRestructuringBenefits
128000
opgn One Time Restructuring Benefits
OneTimeRestructuringBenefits
128000
opgn Retention Expense Expected Cost
RetentionExpenseExpectedCost
63000
CY2017Q2 opgn Retention Expense Cost Incurred
RetentionExpenseCostIncurred
13000
opgn Retention Expense Cost Incurred
RetentionExpenseCostIncurred
13000
opgn Designated Service Period Of Employees Description
DesignatedServicePeriodOfEmployeesDescription
The service period end dates range from the end of August to the end of December 2017
opgn Royalty Income Expense
RoyaltyIncomeExpense
-145802
CY2017Q2 opgn Future Minimum Royalty Payments Due
FutureMinimumRoyaltyPaymentsDue
250000
CY2017Q2 opgn Royalty Income Expense
RoyaltyIncomeExpense
-62941
CY2016Q2 opgn Royalty Income Expense
RoyaltyIncomeExpense
-75948
opgn Royalty Income Expense
RoyaltyIncomeExpense
-132186

Files In Submission

Name View Source Status
0001564590-17-017267-index-headers.html Edgar Link pending
0001564590-17-017267-index.html Edgar Link pending
0001564590-17-017267.txt Edgar Link pending
0001564590-17-017267-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
opgn-10q_20170630.htm Edgar Link pending
opgn-20170630.xml Edgar Link completed
opgn-20170630.xsd Edgar Link pending
opgn-20170630_cal.xml Edgar Link unprocessable
opgn-20170630_def.xml Edgar Link unprocessable
opgn-20170630_lab.xml Edgar Link unprocessable
opgn-20170630_pre.xml Edgar Link unprocessable
opgn-ex311_6.htm Edgar Link pending
opgn-ex312_8.htm Edgar Link pending
opgn-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending